COMPUGEN USA INC has a total of 19 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are GEADIC BIOTEC AIE, BLOOD CENTER OF SOUTHEASTERN W and GENEOHM SCIENCES CANADA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 3 | |
#4 | Canada | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Pollock Sarah | 19 |
#2 | Diber Alexander | 17 |
#3 | Novik Amit | 17 |
#4 | Levine Zurit | 16 |
#5 | Ayalon-Soffer Michal | 15 |
#6 | Akiva Pinchas | 14 |
#7 | Dahary Dvir | 14 |
#8 | Sorek Rotem | 14 |
#9 | Toporik Amir | 13 |
#10 | Sella-Tavor Osnat | 12 |
Publication | Filing date | Title |
---|---|---|
AU2005207886A1 | Novel brain natriuretic peptide variants and methods of use thereof | |
WO2006131783A2 | Polynucleotides, polypeptides, and diagnosing lung cancer | |
EP1732943A2 | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer | |
EP1735342A2 | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis | |
CA2554440A1 | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer | |
WO2006021874A2 | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer | |
WO2005084116A2 | Calcium channel variants |